ConductScience.org, home

Paper973986

The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.

Roberts CJ and 3 others. Br J Clin Pharmacol, 1976. Cited by 93 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Papers, record 973986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/973986

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
5.07
iCite
Revised in PubMed
2019-05-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roberts CJC J
2Jackson LL
3Halliwell MM
4Branch RAR A

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntipyrineMajor topic
Indocyanine GreenMajor topic
LiverMajor topic
PhenobarbitalMajor topic
Adult
Biotransformation
Female
Humans
Liver Function Tests
Male
Ultrasonics

Source PubMed

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113,844,597The use of indocyanine green for the evaluation of hepatic function and blood flow in man.Am J Dig Dis1960https://conductscience.org/library/papers/13844597PubMed
25,650,142Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance.J Pharmacol Exp Ther1968https://conductscience.org/library/papers/5650142PubMed
313,809,697Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction.J Clin Invest1960https://conductscience.org/library/papers/13809697PubMed
413,689,739The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.Clin Sci1961https://conductscience.org/library/papers/13689739PubMed
51,234,506Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man.Br J Clin Pharmacol1975https://conductscience.org/library/papers/1234506PubMed
65,087,064The stimulant effect of drugs on indocyanine green clearance by the liver.Gut1972https://conductscience.org/library/papers/5087064PubMed
74,144,102Determination of drug metabolizing enzymes in needle biopsies of human liver.Eur J Clin Pharmacol1972https://conductscience.org/library/papers/4144102PubMed
84,150,321Relationship between plasma antipyrine half-lives and hepatic microsomal drug metabolism in dogs.Pharmacology1973https://conductscience.org/library/papers/4150321PubMed
94,205,524Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.J Clin Invest1974https://conductscience.org/library/papers/4205524PubMed
104,428,060Quantitation of tumor volumes and response to therapy with ultrasound B-scans.Radiology1974https://conductscience.org/library/papers/4428060PubMed
114,784,365Plasma antipyrine half-life and hepatic microsomal antipyrine hydroxylase activity in rabbits.Pharmacology1973https://conductscience.org/library/papers/4784365PubMed
124,746,322Hemodynamic drug interactions: the reduction of oxyphenbutazone clearance by dl-propranol in the dog.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4746322PubMed
134,698,657Hepatic bilirubin UDP-glucuronyl transferase activity and cytochrome P450 content in a surgical population, and the effects of preoperative drug therapy.J Lab Clin Med1973https://conductscience.org/library/papers/4698657PubMed
145,045,968Liver volume determination by ultrasonic scanning.Br J Radiol1972https://conductscience.org/library/papers/5045968PubMed
155,114,497Changes in liver blood flow during enzyme induction.Biochem Pharmacol1971https://conductscience.org/library/papers/5114497PubMed
165,389,794Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.J Clin Invest1969https://conductscience.org/library/papers/5389794PubMed

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
39,063,098Analysis of Carcinogenic Involvement of MicroRNA Pattern in Peripheral Non-Cancerous Tissues and Chronic Viral Liver Injury.Int J Mol Sci2024https://conductscience.org/library/papers/39063098PubMed
34,880,776Physiologically Based Modeling of the Effect of Physiological and Anthropometric Variability on Indocyanine Green Based Liver Function Tests.Front Physiol2021https://conductscience.org/library/papers/34880776PubMed
11,392,451Body surface area as a determinant of pharmacokinetics and drug dosing.Invest New Drugs2001https://conductscience.org/library/papers/11392451PubMed
9,833,597Relationships among liver and kidney volumes, lean body mass and drug clearance.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9833597PubMed
8,491,059Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.Clin Pharmacokinet1993https://conductscience.org/library/papers/8491059PubMed
8,013,162Lean body mass as a predictor of drug dosage. Implications for drug therapy.Clin Pharmacokinet1994https://conductscience.org/library/papers/8013162PubMed
7,737,036Pharmacokinetics in the elderly.Environ Health Perspect1994https://conductscience.org/library/papers/7737036PubMed
7,389,235Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine.Clin Pharmacokinet1980https://conductscience.org/library/papers/7389235PubMed
7,389,234Antipyrine half-life and drug elimination.Clin Pharmacokinet1980https://conductscience.org/library/papers/7389234PubMed
7,333,060Disposition of antipyrine and phenytoin correlated with age and liver volume in man.Clin Pharmacokinet1981https://conductscience.org/library/papers/7333060PubMed
7,117,357Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7117357PubMed
7,082,041Liver volume estimation using ultrasound scanning.Arch Dis Child1982https://conductscience.org/library/papers/7082041PubMed
7,059,438Differential effects of enzyme induction on antipyrine metabolite formation.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7059438PubMed
6,861,869Relationships between plasma theophylline clearance, liver volume and body weight in children and adults.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6861869PubMed
6,849,748A link between liver microsomal enzyme activity and thyroid hormone metabolism in man.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6849748PubMed
6,832,206Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6832206PubMed
6,693,040Effects of chronic oral cimetidine on apparent liver blood flow and hepatic microsomal enzyme activity in man.Gut1984https://conductscience.org/library/papers/6693040PubMed
6,628,504Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6628504PubMed
6,508,980Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6508980PubMed
6,487,478The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6487478PubMed

See all 39 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/973986

GET https://conductscience.org/api/papers/v1/973986/cited_by?page=2